Related Experiment Video
Updated: May 30, 2025

10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
9.5K
Predicting brain tumour growth patterns using a novel MRI-based tumour spread map: application to radiotherapy
Parandoush Abbasian1,2,3, Lawrence Ryner1,2,3, Boyd McCurdy1,2,3
1Physics and Astronomy, University of Manitoba, Winnipeg, Canada.
Medical Physics
|January 26, 2025
Summary
This study introduces a novel tumour spread (TS) map using diffusion tensor imaging (DTI) to predict glioblastoma recurrence. The TS map optimizes radiation therapy by targeting high-risk areas, improving treatment efficacy and normal tissue preservation.
Area of Science:
- Neuro-oncology
- Radiotherapy Physics
- Medical Imaging Analysis
Background:
- Glioblastoma (GBM) treatment is challenging due to invasive growth and high recurrence rates within normal brain tissue.
- Current radiotherapy approaches struggle to effectively target diffuse tumour spread.
Purpose of the Study:
- To introduce a new metric, the tumour spread (TS) map, utilizing diffusion tensor imaging (DTI).
- To hypothesize that the TS map can predict GBM recurrence patterns and guide radiation therapy modifications.
- To pre-emptively target regions at high risk of tumour spread for improved treatment outcomes.
Main Methods:
- Diffusion tensor tractography was used to visualize white matter fiber tracts.
- A novel algorithm generated a TS map calculating voxel-wise probability of tumour spread.
- Radiotherapy target volumes were modified based on TS map predictions for Volumetric Modulated Arc Therapy (VMAT) planning.
Main Results:
- A TS map successfully predicted tumour spread along fiber tracts in a GBM patient.
- The modified target volume improved coverage of high-risk areas with a 21% reduction in overall volume.
- The modified VMAT plan delivered a higher dose (80% vs. 63%) to identified recurrences, preserving more normal tissue.
Conclusions:
- Tractography-based TS maps show promise for predicting GBM recurrence and optimizing radiotherapy.
- Further validation in larger patient cohorts is necessary.
- TS maps may enable personalized treatment strategies for glioblastoma.

